Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option? Margot Zöller Review 06 April 2004 Pages: 659 - 676
How should clinical data be included in experimental studies of cancer immunology? Bjørn Tore GjertsenØystein Bruserud Opinion Paper 07 April 2004 Pages: 677 - 680
The effect of LIGHT in inducing maturation of monocyte-derived dendritic cells from MDS patients Gang-Ming ZouJeff MartinsonHans G. Klingemann Original Article 20 April 2004 Pages: 681 - 689
Antitumor effects of fusions composed of dendritic cells and fibroblasts transfected with genomic DNA from tumor cells Motoyuki NakamuraTetsuro KikuchiTsuneya Ohno Original Article 16 March 2004 Pages: 690 - 696
CpG-Oligodeoxynucleotides activate tyrosinase-related protein 2–specific T lymphocytes but do not lead to a protective tumor-specific memory response Lucia SfondriniDario BesussoAndrea Balsari Original Article 18 March 2004 Pages: 697 - 704
Generation of dendritic cell–tumor cell hybrids by electrofusion for clinical vaccine application Katrina T. TrevorCathleen CoverRichard E. Walters Original Article 26 March 2004 Pages: 705 - 714
Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates Marieke GriffioenMartina BorghiDirk Schadendorf Original Article 03 March 2004 Pages: 715 - 722
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes Jan JosephBernd NiggemannFrank Entschladen Original Article 18 March 2004 Pages: 723 - 728
Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma Frede DonskovKaren Marie BennedsgaardHans von der Maase Original Article 15 April 2004 Pages: 729 - 739
Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia Øystein WendelboIngerid NesthusØystein Bruserud Original Article 05 May 2004 Pages: 740 - 747
An epigenetically altered tumor cell vaccine A. Nazmul H. KhanWilliam J. MagnerThomas B. Tomasi Original Article 28 February 2004 Pages: 748 - 754
Strategies for immune therapy: Würzburg, Germany, 29 February–3 March 2004 G. PawelecC. Gouttefangeas Meeting Report 04 May 2004 Pages: 755 - 758